Market Cap 295.14B
Revenue (ttm) 42.11B
Net Income (ttm) 14.64B
EPS (ttm) N/A
PE Ratio 21.04
Forward PE 17.82
Profit Margin 34.78%
Debt to Equity Ratio 0.72
Volume 13,071,300
Avg Vol 9,254,448
Day's Range N/A - N/A
Shares Out 4.49B
Stochastic %K 28%
Beta 0.65
Analysts Sell
Price Target $102.38

Latest News on NVO

Novo Nordisk: It's Not Been This Cheap For Many Years

May 9, 2025, 11:30 AM EDT - 2 days ago

Novo Nordisk: It's Not Been This Cheap For Many Years


Novo Nordisk A/S (NVO) Q1 2025 Earnings Call Transcript

May 7, 2025, 12:05 PM EDT - 4 days ago

Novo Nordisk A/S (NVO) Q1 2025 Earnings Call Transcript


Novo Nordisk Stock Jumps Despite Full-Year Outlook Cut

May 7, 2025, 6:26 AM EDT - 4 days ago

Novo Nordisk Stock Jumps Despite Full-Year Outlook Cut


U.S. FDA accepts Novo Nordisk's application for oral Wegovy

May 2, 2025, 2:41 PM EDT - 9 days ago

U.S. FDA accepts Novo Nordisk's application for oral Wegovy


Why Is Novo Nordisk Stock Trading Higher On Friday?

May 2, 2025, 2:24 PM EDT - 9 days ago

Why Is Novo Nordisk Stock Trading Higher On Friday?


The GLP-1 Saga Continues, And How

May 1, 2025, 9:05 PM EDT - 10 days ago

The GLP-1 Saga Continues, And How

LLY PFE


Novo Nordisk: The Fear Is Overblown

May 1, 2025, 2:24 AM EDT - 10 days ago

Novo Nordisk: The Fear Is Overblown


Why New Wegovy Deals Won't Restore Novo Nordisk's Obesity Lead

Apr 30, 2025, 5:30 AM EDT - 11 days ago

Why New Wegovy Deals Won't Restore Novo Nordisk's Obesity Lead


Growth Is Priced Out Of Novo Nordisk

Apr 29, 2025, 2:29 PM EDT - 12 days ago

Growth Is Priced Out Of Novo Nordisk


Pharma firms maastraz

Apr 29, 2025, 12:06 PM EDT - 12 days ago

Pharma firms maastraz

AZN GSK NVS


Hims & Hers partners with Novo Nordisk to sell Wegovy

Apr 29, 2025, 11:20 AM EDT - 12 days ago

Hims & Hers partners with Novo Nordisk to sell Wegovy

HIMS